Clinical Trial Update: XELOX Versus FOLFOX for Advanced Gastric Cancer (AGC) [Phase 3]

View source ↗

Summary

A Phase 3 trial comparing XELOX and FOLFOX in advanced gastric cancer has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric Cancer

Drugs mentioned

• 5-Fluorouracil (Adrucil) (5-Fluorouracil)
• Capecitabine (Xeloda) (Capecitabine)
• Leucovorin (Wellcovorin) (Leucovorin)
• Oxaliplatin (Eloxatin) (oxaliplatin)

Snippet

Sponsor: Dong-A University Hospital | Conditions: Gastric Carcinoma Stage IV | Phase 3 | Status: TERMINATED